Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

alert: Assessment of LEscol in Renal Transplantation

principal researchers

Bengt Fellström (Uppsala University, Sweden)

Hallvard Holdaas (Oslo University Hospital, Norway)

Terje R Pedersen (University of Oslo, Norway)


Novartis Pharma AG


Novartis Pharma AG

key publications